Free Trial

Regeneron Pharmaceuticals (REGN) Dividend Yield, Date & History

Regeneron Pharmaceuticals logo
$605.61 +15.61 (+2.65%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$608.42 +2.80 (+0.46%)
As of 06:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Regeneron Pharmaceuticals Dividend Summary

Dividend Yield
0.58%
Annual Dividend
$3.52
Next
Dividend Payment
Jun. 6
Dividend Payout Ratio
8.96%

Regeneron Pharmaceuticals (REGN) pays an annual dividend of $3.52 per share, with a dividend yield of 0.58%. The next n/a payment of $0.88 per share is scheduled for Friday, June 6, to investors who own the stock before the ex-dividend date of Tuesday, May 20. The company currently pays out 8.96% of its earnings and 8.85% of its cash flow as dividends.

Get Dividend Stock Ideas Daily

Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news.

Sign Up
Skip Charts & View Dividend History

REGN Dividend Payments by Quarter

The chart below displays up to four years of Regeneron Pharmaceuticals' dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.

REGN Dividend Yield Over Time

The chart below tracks Regeneron Pharmaceuticals' dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.

Regeneron Pharmaceuticals vs. The Competition

Compare Regeneron Pharmaceuticals' annual dividend, yield, and 3-year growth rate with averages for Medical and NASDAQ companies to evaluate its performance against the market.

TypeRegeneron PharmaceuticalsMedical CompaniesNASDAQ Companies
Annual Dividend$3.52$0.05$1.29
Dividend Yield0.58%5.36%4.23%
Annualized 3-Year Dividend Growth0.00%5.60%12.19%

Regeneron Pharmaceuticals Dividend Payout Ratio

Dividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.

TypePayout Ratio
Based on Trailing 12 Months of Earnings8.96%
Based on This Year's Estimate9.80%
Based on Next Year's Estimate9.26%
Based on Cashflow8.85%

Regeneron Pharmaceuticals Dividend History by Quarter

AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date
5/4/2025quarterly$0.88 - 0.6%5/20/20255/20/20256/6/2025
2/20/2025quarterly$0.88 - 0.53%2/20/20252/20/20253/20/2025

This table shows Regeneron Pharmaceuticals' dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time.

Regeneron Pharmaceuticals Dividend - Frequently Asked Questions

The current dividend yield for Regeneron Pharmaceuticals is 0.58%. Learn more on REGN's dividend yield history.

The annual dividend for REGN shares is $3.52. Learn more on REGN's annual dividend history.

Regeneron Pharmaceuticals pays n/a dividends to shareholders.

Regeneron Pharmaceuticals's next n/a dividend payment of $0.88 per share will be made to shareholders on Friday, June 6, 2025.

Regeneron Pharmaceuticals's next ex-dividend date is Tuesday, May 20, 2025.

The dividend payout ratio for REGN is:
  • 8.96% based on the trailing year of earnings
  • 9.80% based on this year's estimates
  • 9.26% based on next year's estimates
  • 8.85% based on cash flow

Regeneron Pharmaceuticals' dividend yield of 0.14% is lower than the average Medical company that issues a dividend. Regeneron Pharmaceuticals' dividend payout ratio of 8.96% is at a healthy, sustainable level, below 75% of its earnings.

Looking at the stock as a whole, market analysts rate Regeneron Pharmaceuticals stock as a Moderate Buy, forecasting growth opportunities and potential value appreciation.


This page (NASDAQ:REGN) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners